IDEXX Laboratories, Inc. (NASDAQ:IDXX)
The Company develops, manufactures and distributes products and provides services for the veterinary and the food and water testing markets.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
They are the market leader in their niche...
Recs
Better than BABY
Recs
Expanding company in a segment more or less without any other competitors it has no where to go, but up people are spending more on there pets health which bolds well for IDEXX
Recs
My dad works for them. . how can I go wrong!
Recs
The other positive pitches listed here make good sense to me. I'm in!
Recs
A remarkable and well-managed company with outstanding product lines, excellent market share, and sterling stock performance over previous 5 - 7 years. IDEXX water quality testing protocols alone are patented and enshrined within EPA and International standards, which have fairly high barriers to entry and long development timelines - a deep and wide moat if there ever was one. Nevermind the 30.01 P/E (as of July 2007), this company has lots of room to grow, and will.
Recs
This seems to be a well supported business with a realistic goal for future growth.
Recs
flatperformance for 3 m. great 1st q. due for breakout
Recs
Idexx is about to introduce
a new blood chemistry testing machine for veterinarians.
Everyone I know is spending oodles of money on their pets from hip replacements, diatetes treatments, cancer treatments, all take high tech diagnostic testing.
Baby boom has dollars to spare and is driving the trend toward more sophisticated treatments of their pets. Vets are glad to
buy the new machines and take the money.
Recs
IDEXX will continue to exceed forecasts for the foreseeable future. The largest segment of their business, products and services for the companion animal (dogs and cats) population, thrives in any economic environment. Recently, key acquisitions further strengthening their reference lab business continue to position them for business growth in this segment. Winning additional business for BSE diagnostic test kits (Mad Cow) is gaining more share in that segment. Next year, they will launch another new innovative diagnostic instrument for blood chemistry which will devastate competition in a simliar fashion to what the Lasercyte hematology instrument did a few years back. They do however, need to land some bigger wins in the pharma arena or get out of that business.
Recs
mid cap growth, 10%+ rev growth yoy for last 10 years, + fcf, +10% eps growth yoy for last 10 years...noncyclical business (veterinary, food, agriculture)..
Recs
oversold. (2) day selloff after gap higher.
Looking for retest of all time highs in 2007
Recs
Testing for pets, food and water is the same company...I like all three segments...
Recs
Pricey....is a split in the future?
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 21 - 34 of 34 : « Previous 1 2